Restoring Apoptosis in Pancreatic Cancer Cells by Targeting the Nuclear Factor-κB Signaling Pathway With the Anti-Epidermal Growth Factor Antibody IMC-C225

This publication has 37 references indexed in Scilit:

• The function of multiple IκB : NF-κB complexes in the resistance of cancer cells to Taxol-induced apoptosis
  Oncogene, 2002
• The Epidermal Growth Factor Receptor Engages Receptor Interacting Protein and Nuclear Factor-κB (NF-κB)-inducing Kinase to Activate NF-κB
  Journal of Biological Chemistry, 2001
• Inhibition of NF-κB sensitizes human pancreatic carcinoma cells to apoptosis induced by etoposide (VP16) or doxorubicin
  Oncogene, 2001
• The ErbB signaling network: receptor heterodimerization in development and cancer
  The EMBO Journal, 2000
• Overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma is regulated by constitutively activated RelA
  Oncogene, 1999
• HTLV-I Tax Protein Binds to MEKK1 to Stimulate IκB Kinase Activity and NF-κB Activation
  Cell, 1998
• Epidermal growth factor activation of NF-κB is mediated through IκBα degradation and intracellular free calcium
  Oncogene, 1998
• The Epidermal Growth Factor Receptor Associates with and Recruits Phosphatidylinositol 3-Kinase to the Platelet-derived Growth Factor β Receptor
  Journal of Biological Chemistry, 1998
• NF-κB Is Induced in the Nuclei of Cultured Rat Aortic Smooth Muscle Cells by Stimulation of Various Growth Factors
  Biochemical and Biophysical Research Communications, 1996
• THE NF-κB AND IκB PROTEINS: New Discoveries and Insights
  Annual Review of Immunology, 1996